Literature DB >> 23847153

Headache among CADASIL patients with R544C mutation: prevalence, characteristics, and associations.

Jay Chol Choi1, Sook-Keun Song, Jung Seok Lee, Sa-Yoon Kang, Ji-Hoon Kang.   

Abstract

BACKGROUND AND AIM: There are variations of migraine prevalence in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) among different regions of the world. Previous studies on Asian CADASIL patients have not provided detailed descriptions of the characteristics of their headaches. The aims of this study were to determine prevalence and characteristics of headaches and to investigate associations between headache and other clinical symptoms or brain magnetic resonance imaging (MRI) findings among homogenous group of patients having the same R544C mutation.
METHODS: In this cross-sectional study, we enrolled 53 CADASIL patients with the R544C mutation between May 2010 and April 2011. We obtained the history of headache using a structured questionnaire and detailed interview. Other clinical features and brain MRI findings were also assessed for potential associations.
RESULTS: Overall headache prevalence was 45.3% (24 patients). Among them, 21 patients (87.5%) were classified as having tension-type headache, followed by migraine (two patients) and unclassifiable headaches (one patient). Except for alcohol consumption, no significant associations were observed between the headaches and other clinical features or brain MRI findings.
CONCLUSION: Migraine was found in only 3.8% of CADASIL patients with the R544C mutation. Such a low prevalence of migraine may hinder clinical detection of CADASIL among ethnically Asian patients.

Entities:  

Keywords:  CADASIL; headache; magnetic resonance imaging; migraine; prevalence

Mesh:

Substances:

Year:  2013        PMID: 23847153     DOI: 10.1177/0333102413497598

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  8 in total

1.  Mutation spectrum and genotype-phenotype correlations in 157 Korean CADASIL patients: a multicenter study.

Authors:  Ji-You Min; Seo-Jin Park; Eun-Joo Kang; Seung-Yong Hwang; Sung-Hee Han
Journal:  Neurogenetics       Date:  2021-11-06       Impact factor: 2.660

2.  CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships.

Authors:  Rhea Yan Ying Tan; Hugh Stephen Markus
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

3.  Phenotypic Features of Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Subjects with R544C Mutation.

Authors:  Jung Seok Lee; KeunHyuk Ko; Jung-Hwan Oh; Joon Hyuk Park; Ho Kyu Lee
Journal:  Dement Neurocogn Disord       Date:  2016-03-31

4.  Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population.

Authors:  Remco J Hack; Julie W Rutten; Thomas N Person; Jiang Li; Ayesha Khan; Christoph J Griessenauer; Vida Abedi; Saskia A J Lesnik Oberstein; Ramin Zand
Journal:  Stroke       Date:  2020-11-09       Impact factor: 7.914

5.  Case Report: Progressive Asymmetric Parkinsonism Secondary to CADASIL Without Dementia.

Authors:  Weihang Guo; Baolei Xu; Hong Sun; Jinghong Ma; ShanShan Mei; Jingrong Zeng; Junyan Sun; Erhe Xu
Journal:  Front Neurol       Date:  2022-01-10       Impact factor: 4.003

Review 6.  Recurrent generalized seizures as the prominent manifestation in a patient with CADASIL: a case report and literature review.

Authors:  Liuhua Pan; Yan Chen; Shanshan Zhao
Journal:  BMC Neurol       Date:  2022-09-30       Impact factor: 2.903

7.  Characterization of CADASIL among the Han Chinese in Taiwan: Distinct Genotypic and Phenotypic Profiles.

Authors:  Yi-Chu Liao; Cheng-Tsung Hsiao; Jong-Ling Fuh; Chang-Ming Chern; Wei-Ju Lee; Yuh-Cherng Guo; Shuu-Jiun Wang; I-Hui Lee; Yo-Tsen Liu; Yen-Feng Wang; Feng-Chi Chang; Ming-Hung Chang; Bing-Wen Soong; Yi-Chung Lee
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 8.  The Migraine-Stroke Connection.

Authors:  Mi Ji Lee; Chungbin Lee; Chin-Sang Chung
Journal:  J Stroke       Date:  2016-05-31       Impact factor: 6.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.